KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Repurchased
Ratios

Pacira BioSciences (PCRX) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Pacira BioSciences (PCRX) over the last 14 years, with Sep 2025 value amounting to $21.2 million.

  • Pacira BioSciences' Accumulated Depreciation & Amortization rose 4.63% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.9 million, marking a year-over-year increase of 19.59%. This contributed to the annual value of $78.8 million for FY2024, which is 4.25% up from last year.
  • Pacira BioSciences' Accumulated Depreciation & Amortization amounted to $21.2 million in Q3 2025, which was down 22.44% from $27.3 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Accumulated Depreciation & Amortization peaked at $30.4 million during Q4 2022, and registered a low of $4.9 million during Q1 2021.
  • Over the past 3 years, Pacira BioSciences' median Accumulated Depreciation & Amortization value was $19.6 million (recorded in 2023), while the average stood at $20.4 million.
  • Per our database at Business Quant, Pacira BioSciences' Accumulated Depreciation & Amortization skyrocketed by 326.06% in 2022 and then plummeted by 39.21% in 2023.
  • Over the past 5 years, Pacira BioSciences' Accumulated Depreciation & Amortization (Quarterly) stood at $13.1 million in 2021, then skyrocketed by 132.64% to $30.4 million in 2022, then plummeted by 39.21% to $18.5 million in 2023, then rose by 14.92% to $21.2 million in 2024, then climbed by 4.63% to $21.2 million in 2025.
  • Its Accumulated Depreciation & Amortization was $21.2 million in Q3 2025, compared to $27.3 million in Q2 2025 and $21.2 million in Q1 2025.